Coeptis Therapeutics Holdings Inc (COEP) Shares Rise Despite Market Challenges

The stock of Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) has increased by 6.68 when compared to last closing price of 0.29.Despite this, the company has seen a gain of 2.34% in its stock price over the last five trading days. InvestorPlace reported 2023-05-03 that What would happen if performance grading suddenly disappeared? No more dreaded annual job reviews

Is It Worth Investing in Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) Right Now?

The 36-month beta value for COEP is also noteworthy at -0.89. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for COEP is 23.11M, and at present, short sellers hold a 0.17% of that float. The average trading volume of COEP on April 03, 2024 was 218.30K shares.

COEP’s Market Performance

COEP’s stock has seen a 2.34% increase for the week, with a -41.83% drop in the past month and a -59.85% fall in the past quarter. The volatility ratio for the week is 9.55%, and the volatility levels for the past 30 days are at 11.52% for Coeptis Therapeutics Holdings Inc The simple moving average for the past 20 days is -17.77% for COEP’s stock, with a -67.28% simple moving average for the past 200 days.

COEP Trading at -32.42% from the 50-Day Moving Average

After a stumble in the market that brought COEP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.63% of loss for the given period.

Volatility was left at 11.52%, however, over the last 30 days, the volatility rate increased by 9.55%, as shares sank -41.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -42.78% lower at present.

During the last 5 trading sessions, COEP rose by +2.34%, which changed the moving average for the period of 200-days by -82.02% in comparison to the 20-day moving average, which settled at $0.3715. In addition, Coeptis Therapeutics Holdings Inc saw -59.85% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at COEP starting from DeSilva Tara, who purchase 2,266 shares at the price of $0.58 back on Jan 12 ’24. After this action, DeSilva Tara now owns 32,266 shares of Coeptis Therapeutics Holdings Inc, valued at $1,305 using the latest closing price.

Cogley Brian, the Chief Financial Officer of Coeptis Therapeutics Holdings Inc, purchase 5,000 shares at $0.67 during a trade that took place back on Jan 10 ’24, which means that Cogley Brian is holding 30,000 shares at $3,350 based on the most recent closing price.

Stock Fundamentals for COEP

The total capital return value is set at -3.77. Equity return is now at value -485.13, with -266.05 for asset returns.

Based on Coeptis Therapeutics Holdings Inc (COEP), the company’s capital structure generated 0.17 points at debt to capital in total, while cash flow to debt ratio is standing at -6.39. The debt to equity ratio resting at 0.2. The interest coverage ratio of the stock is -153.91.

Currently, EBITDA for the company is -21.49 million with net debt to EBITDA at 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.76.


In summary, Coeptis Therapeutics Holdings Inc (COEP) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts